Package Label (Principal Display Panel)
Voraxaze® (Glucarpidase) is an injectable medication with NDC code 50633-210-11. A readable price is not available.*
Voraxaze Injection, Powder, For Solution
Product Images NDC 50633-210
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Voraxaze (NDC 50633-210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Btg International Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label (Principal Display Panel)
This text contains information related to Voraxaze® medication, which is a Glucarpidase medication for injection, which is available in single-use vials. The package's sole vial contains 1000 units of Glucarpidase, lactose monohydrate, Tris-HCI, and zinc acetate dihydrate with dosage instructions and other information. Voraxaze® is a registered trademark of Proterics Medicines Development L, and the medication is manufactured by BTG International Inc. located in Brentwood, TN, USA. The package also contains information regarding storage conditions and precautions related to the medication.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
